A Registry to Evaluate the Performance of the BDX-XL2 Test

CompletedOBSERVATIONAL
Enrollment

842

Participants

Timeline

Start Date

October 16, 2018

Primary Completion Date

May 12, 2022

Study Completion Date

May 23, 2024

Conditions
Nodule Solitary PulmonaryNSCLC
Trial Locations (15)

15801

Clinical Research Associates of Central PA/Penn Highlands Hospital, DuBois

27103

Southeastern Research Center, Winston-Salem

27858

East Carolina University, Greenville

28374

Pinehurst Medical Clinic, Pinehurst

34239

Sarasota Memorial Hospital, Sarasota

45267

University of Cincinnati, Cincinnati

46845

Parkview Research Center, Fort Wayne

53226

Medical College of Wisconsin, Milwaukee

81003

Pueblo Pulmonary Associates, Pueblo

85351

Banner Health, Sun City

89154

University of Nevada, Las Vegas, Las Vegas

91324

Amicis Research Center, Northridge

97220

The Oregon Clinic, Portland

98225

Peacehealth, Bellingham

06904

Stamford Health, Stamford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biodesix, Inc.

INDUSTRY

NCT03766958 - A Registry to Evaluate the Performance of the BDX-XL2 Test | Biotech Hunter | Biotech Hunter